6.90
price down icon6.76%   -0.50
after-market Dopo l'orario di chiusura: 7.10 0.20 +2.90%
loading
Precedente Chiudi:
$7.40
Aprire:
$7.32
Volume 24 ore:
328.96K
Relative Volume:
2.04
Capitalizzazione di mercato:
$109.76M
Reddito:
$1.54M
Utile/perdita netta:
$-38.70M
Rapporto P/E:
-1.4775
EPS:
-4.67
Flusso di cassa netto:
$-36.86M
1 W Prestazione:
-12.55%
1M Prestazione:
-7.01%
6M Prestazione:
-41.53%
1 anno Prestazione:
-84.75%
Intervallo 1D:
Value
$6.85
$7.43
Intervallo di 1 settimana:
Value
$6.85
$8.705
Portata 52W:
Value
$4.64
$61.90

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name
Nome
Corbus Pharmaceuticals Holdings Inc
Name
Telefono
617-963-0103
Name
Indirizzo
500 RIVER RIDGE DRIVE, NORWOOD, MA
Name
Dipendente
28
Name
Cinguettio
@corbuspharma
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
CRBP's Discussions on Twitter

Confronta CRBP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CRBP
Corbus Pharmaceuticals Holdings Inc
6.90 109.76M 1.54M -38.70M -36.86M -4.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.20 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
525.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.09 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
551.22 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
242.07 28.51B 3.81B -644.79M -669.77M -6.24

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-28 Iniziato William Blair Outperform
2024-12-02 Iniziato Piper Sandler Overweight
2024-07-30 Iniziato Wedbush Outperform
2024-07-22 Ripresa H.C. Wainwright Buy
2024-06-26 Iniziato B. Riley Securities Buy
2024-06-03 Reiterato Oppenheimer Outperform
2024-05-13 Iniziato RBC Capital Mkts Outperform
2024-03-06 Aggiornamento Jefferies Hold → Buy
2020-09-08 Downgrade BTIG Research Buy → Neutral
2020-09-08 Downgrade Jefferies Buy → Hold
2020-09-08 Downgrade RBC Capital Mkts Outperform → Sector Perform
2020-09-08 Downgrade ROTH Capital Buy → Neutral
2020-07-07 Iniziato ROTH Capital Buy
2020-06-17 Iniziato BTIG Research Buy
2020-03-26 Iniziato Nomura Buy
2019-04-05 Iniziato Jefferies Buy
2019-03-20 Iniziato Oppenheimer Outperform
2019-01-11 Reiterato Cantor Fitzgerald Overweight
2018-12-26 Iniziato H.C. Wainwright Buy
2018-12-07 Iniziato RBC Capital Mkts Outperform
2018-10-24 Iniziato B. Riley FBR Buy
2018-01-19 Iniziato Raymond James Outperform
2017-12-14 Reiterato Cantor Fitzgerald Overweight
2017-11-08 Reiterato Noble Financial Buy
2017-09-29 Ripresa Noble Financial Buy
2017-03-30 Reiterato Cantor Fitzgerald Overweight
2016-11-15 Reiterato JMP Securities Mkt Outperform
2016-11-11 Reiterato Noble Financial Buy
Mostra tutto

Corbus Pharmaceuticals Holdings Inc Borsa (CRBP) Ultime notizie

pulisher
Jun 17, 2025

Corbus Pharmaceuticals: Is Its Pipeline Really Worthless After Novo's Negative Data? - Seeking Alpha

Jun 17, 2025
pulisher
Jun 15, 2025

Analysts Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) PT at $50.88 - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Bank of America Corp DE Buys 7,207 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 13, 2025
pulisher
Jun 08, 2025

11,027 Shares in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Bought by Two Sigma Advisers LP - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

(CRBP) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Has $341,000 Stake in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Dermatomyositis Market Predicted to See Upsurge Through 2034, - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

Two Sigma Investments LP Purchases 91,205 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Deutsche Bank AG - Defense World

Jun 04, 2025
pulisher
May 29, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Millennium Management LLC - Defense World

May 29, 2025
pulisher
May 29, 2025

Northern Trust Corp Acquires 11,400 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

May 29, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Makes New Investment in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

May 27, 2025
pulisher
May 26, 2025

(CRBP) Proactive Strategies - news.stocktradersdaily.com

May 26, 2025
pulisher
May 23, 2025

3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies - Zacks Investment Research

May 23, 2025
pulisher
May 22, 2025

Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Corbus Pharmaceuticals CEO Set to Reveal Latest Corporate Strategy at Major Jefferies Healthcare Conference - Stock Titan

May 22, 2025
pulisher
May 21, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives $50.88 Average Target Price from Analysts - Defense World

May 21, 2025
pulisher
May 20, 2025

Mizuho Securities Adjusts Corbus Pharmaceuticals Price Target to $32 From $42, Maintains Outperform Rating - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Mizuho Cuts Price Target on Corbus Pharmaceuticals Holdings to $32 From $42, Keeps Outperform Rating - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Cannabis Stock Movers For May 20, 2025 - Benzinga

May 20, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals appoints new board chair - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals appoints new board chair By Investing.com - Investing.com South Africa

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals Appoints New Chair of the Board - TipRanks

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals (CRBP) Names New Chair to Board of Direct - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair - GlobeNewswire

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals Appoints Industry Leader as Chair with 3 Major Clinical Readouts Coming - Stock Titan

May 19, 2025
pulisher
May 16, 2025

(CRBP) Investment Analysis - news.stocktradersdaily.com

May 16, 2025
pulisher
May 16, 2025

Is Small-Cap Corbus Pharma a Worthy Cannabis Investment? - sharewise

May 16, 2025
pulisher
May 13, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Sold by Barclays PLC - Defense World

May 13, 2025
pulisher
May 13, 2025

Wells Fargo & Company MN Has $76,000 Holdings in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

May 13, 2025
pulisher
May 12, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Sold by Tower Research Capital LLC TRC - Defense World

May 12, 2025
pulisher
May 10, 2025

Oppenheimer Cuts Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $56.00 - Defense World

May 10, 2025
pulisher
May 10, 2025

B. Riley Expects Reduced Earnings for Corbus Pharmaceuticals - Defense World

May 10, 2025
pulisher
May 10, 2025

HC Wainwright Cuts Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $40.00 - Defense World

May 10, 2025
pulisher
May 10, 2025

Wedbush Expects Weaker Earnings for Corbus Pharmaceuticals - Defense World

May 10, 2025
pulisher
May 10, 2025

HC Wainwright Issues Negative Forecast for CRBP Earnings - Defense World

May 10, 2025
pulisher
May 09, 2025

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch

May 09, 2025
pulisher
May 09, 2025

Royal Bank of Canada Has Lowered Expectations for Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price - Defense World

May 09, 2025
pulisher
May 08, 2025

Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

Cannabis Stock Tilray Brands Loses 19% in a Month: Time to Sell or Hold? - Zacks Investment Research

May 08, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

May 07, 2025
pulisher
May 07, 2025

CRBP: RBC Capital Lowers Price Target, Maintains Outperform Rati - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Oppenheimer Lowers Price Target for Corbus Pharmaceuticals (CRBP) | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals (CRBP) Target Price Reduced by Analyst | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals (CRBP) Target Price Adjusted by RBC Capital | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

CRBP: HC Wainwright & Co. Lowers Price Target for Corbus Pharmaceuticals | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Oppenheimer Adjusts Price Target for Corbus Pharmaceuticals (CRBP) | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

RBC Cuts Price Target on Corbus Pharmaceuticals Holdings to $58 From $65, Keeps Outperform, Speculative Risk - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals (CRBP) Sees Price Target Reduction | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals: Q1 Earnings Snapshot - CTPost

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewswire

May 07, 2025

Corbus Pharmaceuticals Holdings Inc Azioni (CRBP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Corbus Pharmaceuticals Holdings Inc Azioni (CRBP) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Altmeyer Anne
Director
May 30 '25
Sale
7.25
1,392
10,096
1,391
Smethurst Dominic
Chief Medical Officer
Mar 06 '25
Sale
6.78
6,393
43,330
70,807
$20.66
price up icon 0.78%
$36.03
price up icon 0.45%
$21.28
price up icon 3.30%
$100.64
price up icon 1.16%
$106.47
price down icon 0.23%
biotechnology ONC
$242.07
price up icon 0.36%
Capitalizzazione:     |  Volume (24 ore):